LabTurbo Biotech Corporation of Taipei at MEDICA 2020 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option

LabTurbo Biotech Corporation

3f-1, No. 150, Section 4, Chen-De Rd., 111052 Taipei
Taiwan
Telephone +886 22889 1136
Fax +886 22889 1146

Contact

Evan Lin

Sales manager

Hamilton Township, New Jersey, USA

Phone
+16096191858

Email
evanlin@labturbo.com.tw

Joe Yu

Sales

Taipei, Taiwan

Phone
+886916371127

Email
joeyu@labturbo.com.tw

Tina Tsai

Sales

Hamilton Township, New Jersey, USA

Phone
+16093755416

Email
tina@labturbo.com.tw

Emily Chiang

Phone
+13476088634

Email
echiang@labturbo.com.tw

Visit us

Unsettled / NN

16.11.2020

Topic

all-day

Product presentation and inquiry

One by One consultation and Q&A

More Less

17.11.2020

Topic

all-day

Product presentation and inquiry

One by One consultation and Q&A

More Less

18.11.2020

Topic

all-day

Product presentation and inquiry

One by One consultation and Q&A

More Less

19.11.2020

Topic

all-day

Product presentation and inquiry

One by One consultation and Q&A

More Less

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.05  Infectious immunology testing
  • 03.05.01  Bacteriology testing

Bacteriology testing

  • 03  Diagnostic tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.02  Molecular biomarkers
  • 03  Diagnostic tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.03  Polymerase chain reaction (PCR)

Polymerase chain reaction (PCR)

Our products

Product category: DNA testing, Molecular biomarkers

LabTurbo AIO 48 SP-qPCR Automation System

High-Throughput, Speedy, Truly Walk-away
Sample-to-result Coronavirus SARS-CoV-2 detection

All-In-One(Sample-to-result) procedure: LabTurbo COVID-19 testing platform automates the whole detection procedure from sample to PCR results. Get 1 to 48 COVID testings done in 2 hours!

  • Simple mode:
    Throghput 1-48 in 2 hours
  • Simultaneously workflow mode:
    Runing sample extraction and PCR at the same time
    Only take 2 hours to finish first batch 48 samples, 48 samples PCR result per 1 hour after the first run.
  • Mass Rapid Transit Mode:
    Operated by One AIO with two LabTurbo C48, 144 sample PCR result per 1 hour after the first run(2 hours)
    Only take 1.32 square meter in lab

DIM: 66 x 72 x 170 cm (26 x 28 x 67 in)

Weight: 250 kg

Pipette Channel: 6 Channel

Pipette volume range: 5 -1000 ul

5-Channels for qPCR: FAM、HEX、Texas Red、CY5、CY5.5

Extraction Process time: 1-48 samples in an hour

qPCR process time (40cycle): 1- 1.5 hour

Sample throughput: 1-48 samples per run on extraction, 1-144 tests per run on PCR

Sample input volume: 0.3-3 ml

Elution volume: 50-200 ul

TFDA EUA Approval  

More Less

Product category: DNA testing, Molecular biomarkers

LabTurbo 48 Compact System

Function: Sampling from Primary sample tube, Sample lysis, DNA/RNA Extraction, Simple PCR Setup(Optional), Self testing, liquid level detection, Auto-Worktable Clean And Recovery

DIM: 66 x 64 x 160 cm (26 x 26 x 63 in)

Weight: 200 kg

Pipette Channel: 6 Channel.

Pipette volume range: 5 -1000 ul

Process time: 90 mins

Sample throughput: 1-48 samples per run

Sample input volume: 0.3-3 ml

Elution volume: 50-200 ul

More Less

Product category: DNA testing, Molecular biomarkers

LabTurbo 24 Compact System

Function: Sampling from Primary sample tube, Sample lysis, DNA/RNA Extraction, Simple PCR Setup(Optional), Self testing, liquid level detection, Auto-Worktable Clean And Recovery

DIM: 66 x 53 x 82 cm (26 x 21 x 33 in)

Weight 80 kg

Pipette Channel: 6 Channel.

Pipette volume range: 5 -1000 ul

Process time: 70 mins

Sample throughput: 1-24 samples per run

Sample input volume: 0.3-3 ml

Elution volume: 50-200 ul

More Less

Product category: DNA testing

LabTurboTM AIO COVID-19 RNA Testing Kit(480)

LabTurboTM AIO COVID-19 RNA Testing Kit includes two products, Acov11240 and Acov13000. They contain oligonucleotide primers, dual-labeled hydrolysis probes, and control material used in RT-qPCR for the in vitro qualitative detection of SARS-CoV-2 (COVID-19) RNA in respiratory specimens. They are designed for assay and validation:
• Table 1. Detection Target in LabTurboTM AIO COVID-19 RNA Testing Kit Assay
Cat. No.: Acov11240
N gene(FAM)
E gene(HEX)
Endogenous IC(Cy5)

Cat. No.:Acov13000
RdRP(FAM)

Patient swab cell
COVID-19 Dye

The product, Kit No. Acov11240, is a multiplex RT-qPCR assay for N gene, E gene, and endogenous IC in the specimens. N gene is specifically used to validate SARS-CoV-2 (COVID-19) in specimens; the E gene is used to validate universal SARS-CoV RNA. RNase P (RP) is used as an endogenous Internal Control (IC) to validate successful specimen collection from individual patients. The Acov13000 kit is a singleplex RT-qPCR assay for the RdRP gene as a confirmatory validation for the presence of SARS-CoV-2 from specimens with negative N gene detection and positive E gene detection. Furthermore, thePositive Extraction Control (PEC) can validate the workflow and performance of the assay. The RNase-free water is used as the negative extraction control (NEC) to validate the reagent stability and monitor cross-contamination. Both PEC and NEC have to be validated in every batch of the assay. The positive control (PC) is used to validate the RT-qPCR performance if the PEC fails due to extraction; the negative control (NC) is used to confirm cross-contamination if the NEC fails due to extraction.
The assays could be completed using the fully automated instrument LabTurbo AIO SP-qPCR System (LabTurboTM AIO), or using the semi-automation LabTurbo 48 compact system (CE IVD), as an extractor, and with a RT-qPCR machine, such as the QuantStudioTM 5 Real-Time PCR Systems, manufactured by ThermoFisher. All systems can use the LabTurboTM Viral DNA/RNA Mini kit (LVX480-500) for nucleic acid extraction and the LabTurboTM AIO COVID-19 RNA Testing Kit (Acov11240 and Acov13000) for RT-qPCR assay.

More Less

Product category: DNA testing

LabTurbo Extraction kit

LabTurbo Extraction kit can be applied to various application,

  • Ready to use. Minimal preparation is needed
  • Use the exact amount of reagents and consumables. No waste of kit.
  • Reagents can be stored on the system for 3 months for ease of use
  • Kit can be stored in room temperature for 1 year

Kit contains LabTurbo sample tubes, elution tubes, column sets,
reagents, and proteinase K. Filtered tips can be purchased separately.
Ethanol is to be provided by users.

More Less

Product category: DNA testing, Molecular biomarkers

LabTurbo Reaction (PCR) Setup System

Liquid-handling System
Fast & Precise PCR setup for 96 and 384-well plate

Size (cm): 66 x 53 x 70

Weight (kg):  60 (Bench-top)

Transfer volume: 2-50 ul

Master mix wells: up to 20

Sample wells: 1-96 wells

Pipette channels: 6(Sliding span 9-18 mm)

Cooling temperature: 10 ± 2 °C(at room temperature)

PCR plate format: 96 and 384 well plate

Throughput: 96 well transfer in 15 minutes / 384 well transfer in 35 minutes

More Less

Company news

Date

Topic

Download

May 12, 2020

LabTurbo COVID-19 RNA detection products have obtained approval by Taiwan FDA

2020/5/12 Global Bio & investment

The LabTurbo COVID-19 RNA detection products, including LabTurbo AIO RNA Detection Kit, LabTurbo AIO Viral DNA/RNA  Extraction Kit, and LabTurbo AIO SP-qPCR System have obtained approval by Taiwan FDA.

Approval period: From 11 March, 2020 until the disbandment of Central Epidemic Command Center (CECC), Taiwan.

 

Approval lists by Taiwan FDA (File download):
Approval number: 1096806630;Approved products: LabTurbo AIO COVID-19 RNA Testing Kit (AIOQS3480)、LabTurbo Viral DNA/RNA AIO extraction Kit (AIOLVX500)、LabTurbo AIO SP-qPCR system (AIO48S-144)。

More Less

About us

Company details

「LabTurbo」 was originally an automated nucleic acid department established by “Taigen Bioscience Co., Ltd." in 2000. For the past 20 years, it has focused on the development of nucleic acid application automation technology, product manufacturing and sales. It has successively developed more than 10 invention patents across Taiwan, the United States, China, Japan, South Korea, Germany and other countries, and began to deploy the global nucleic acid application market.

        Based on the vigorous development of the global genetic testing market, 「 LabTurbo Biotech Co., Ltd.」was formally established in June 2019, and invested funds in the development of nucleic acid fully automated, full-process genetic testing systems, and strengthened the "AIO SP-qPCR" System Application Deepening" and "Global Market Layout".

        LabTurbo products use the exclusive patented「flow membrane tube vacuum method」automatic nucleic acid extraction system, which has been adopted by the American Red Cross with ultra-high sensitivity. For four years, nearly 90,000 bags of blood transfusion of Lyme disease infected DNA Screening; the research results were published in the authoritative medical journal「The New England Journal of Medicine (NEJM)」and obtained the U.S. FDA medical materials certification. This result confirms that the company's branch automation products have reached international standards.

       LabTurbo’s domestic customers cover nearly 40 institutions including hospitals at all levels, private inspection centers, universities, the Central Research Institute, the Food and Drug Administration of the Ministry of Health and Welfare, the Forensic Office of the Police Department, the Department of Disease Control, and the Animal Health Laboratory; The foreign customers are mainly the United States, and there are also product users in Israel, Singapore, and France. It is expected to continue to cultivate the global automated nucleic acid application market and expand the scope of automated genetic testing applications.

More Less

Company data

Export content

max. 75%

Number of employees

50-99

Area of business
  • Laboratory Equipment
  • Diagnostics

Company information as a PDF file